Renal effects of canagliflozin in patients with Type 2 diabetes

被引：0
|
作者：
Wong, Yip Fong [1 ]
Shao, Yanli [1 ]
Sum, Chee Fang [1 ]
机构：
[1] Khoo Teck Puat Hosp, Ctr Diabet, Singapore, Singapore
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2016年 / 120卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PD-90
引用
收藏
页码：S119 / S120
页数：2
相关论文
共 50 条
  • [21] Canagliflozin in type 2 diabetes: Differences in effects between subgroups?
    Simon, Annika
    DIABETOLOGIE UND STOFFWECHSEL, 2022, 17 (06) : 431 - +
  • [22] Renal effects of dapagliflozin in patients with type 2 diabetes
    Thomas, Merlin C.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2014, 5 (03) : 53 - 61
  • [23] Pharmacokinetics and pharmacodynamics of canagliflozin in pediatric patients with type 2 diabetes
    Tamborlane, William V.
    Polidori, David
    Argenti, Domenick
    Di Prospero, Nicholas A.
    PEDIATRIC DIABETES, 2018, 19 (04) : 649 - 655
  • [24] Canagliflozin: A Review in Type 2 Diabetes
    Deeks, Emma D.
    Scheen, Andre J.
    DRUGS, 2017, 77 (14) : 1577 - 1592
  • [25] Canagliflozin (Invokana) for Type 2 Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1416): : 1 - 4
  • [26] Pharmacokinetic and Pharmacodynamic Profiles of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus and Moderate Renal Impairment
    Nobuya Inagaki
    Kazuoki Kondo
    Toru Yoshinari
    Manabu Ishii
    Masaki Sakai
    Hideki Kuki
    Kenichi Furihata
    Clinical Drug Investigation, 2014, 34 : 731 - 742
  • [27] Canagliflozin approved for type 2 diabetes
    Traynor, Kate
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (10) : 834 - 834
  • [28] Canagliflozin: A Review in Type 2 Diabetes
    Emma D. Deeks
    André J. Scheen
    Drugs, 2017, 77 : 1577 - 1592
  • [29] Canagliflozin could improve the levels of renal oxygenation in newly diagnosed type 2 diabetes patients with normal renal function
    Zhou, Saijun
    Zhang, YuLing
    Wang, TongDan
    Huang, Shuai
    Gong, Siyi
    Wang, Junmei
    Yu, Pei
    DIABETES & METABOLISM, 2021, 47 (05)
  • [30] Pharmacokinetic and Pharmacodynamic Profiles of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus and Moderate Renal Impairment
    Inagaki, Nobuya
    Kondo, Kazuoki
    Yoshinari, Toru
    Ishii, Manabu
    Sakai, Masaki
    Kuki, Hideki
    Furihata, Kenichi
    CLINICAL DRUG INVESTIGATION, 2014, 34 (10) : 731 - 742
12345